Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Expressive Neuroscience is a specialized biotechnology service provider and informatics company that offers high-throughput, quantitative neurohistology to accelerate drug discovery for central nervous system (CNS) disorders. The company integrates expert tissue processing and advanced fluorescence microscopy with proprietary machine learning algorithms to provide precise protein quantification and localization at the cellular level. By leveraging full-brain spatialomics and sub-cellular structural analysis, Expressive Neuroscience enables pharmaceutical partners to assess the targeting precision and efficacy of therapeutic candidates across various modalities, including gene therapies and small molecules. Their platform is designed to overcome the limitations of traditional histology by delivering actionable, high-resolution data on cell morphology and neuroanatomical distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Expressive Tek.